BioCentury | Dec 24, 2007
Finance

Ebb & Flow

...covering use of the product in adults in 1Q08. Alta was an early investor in Corgentech...
BioCentury | Dec 17, 2007
Company News

Anesiva, Medical Futures Inc. sales and marketing update

...responsible for all the costs associated with regulatory, distribution, marketing and selling activities. ANSV (formerly Corgentech Inc....
BioCentury | Oct 22, 2007
Company News

Anesiva, Fosun Pharmaceutical Co. Ltd. deal

...be called Wanbang/Anesiva (Jiangsu) Pharmaceuticals Ltd. and will be located in XuZhou, China. ANSV (formerly Corgentech Inc....
BioCentury | Aug 20, 2007
Clinical News

Zingo regulatory update

...covering use of the product in adults by the end of the year. ANSV (formerly Corgentech...
BioCentury | Feb 12, 2007
Finance

Ebb & Flow

...venous access procedures in children. The NDA will receive a standard 10-month review. ANSV (formerly Corgentech...
BioCentury | Feb 12, 2007
Clinical News

Zingo regulatory update

...on Nov. 22, 2006, and will be subject to a standard 10-month review. ANSV (formerly Corgentech...
BioCentury | Feb 8, 2007
Company News

FDA accepts Zingo NDA

...NDA was submitted on Nov. 22 and will receive a standard 10-month review. ANSV (formerly Corgentech...
BioCentury | Dec 4, 2006
Finance

Ebb & Flow

...for Zingo (3268) to treat pain associated with venous access procedures in children. ANSV (formerly Corgentech...
BioCentury | Nov 28, 2006
Company News

Anesiva submits Zingo NDA

...3268) to treat pain associated with venous access procedures in children. ANSV (formerly known as Corgentech...
BioCentury | Nov 22, 2006
Financial News

Anesiva raises $45 million

...The shares were sold from an existing shelf registration. ANSV, which was formerly known as Corgentech...
Items per page:
1 - 10 of 167
BioCentury | Dec 24, 2007
Finance

Ebb & Flow

...covering use of the product in adults in 1Q08. Alta was an early investor in Corgentech...
BioCentury | Dec 17, 2007
Company News

Anesiva, Medical Futures Inc. sales and marketing update

...responsible for all the costs associated with regulatory, distribution, marketing and selling activities. ANSV (formerly Corgentech Inc....
BioCentury | Oct 22, 2007
Company News

Anesiva, Fosun Pharmaceutical Co. Ltd. deal

...be called Wanbang/Anesiva (Jiangsu) Pharmaceuticals Ltd. and will be located in XuZhou, China. ANSV (formerly Corgentech Inc....
BioCentury | Aug 20, 2007
Clinical News

Zingo regulatory update

...covering use of the product in adults by the end of the year. ANSV (formerly Corgentech...
BioCentury | Feb 12, 2007
Finance

Ebb & Flow

...venous access procedures in children. The NDA will receive a standard 10-month review. ANSV (formerly Corgentech...
BioCentury | Feb 12, 2007
Clinical News

Zingo regulatory update

...on Nov. 22, 2006, and will be subject to a standard 10-month review. ANSV (formerly Corgentech...
BioCentury | Feb 8, 2007
Company News

FDA accepts Zingo NDA

...NDA was submitted on Nov. 22 and will receive a standard 10-month review. ANSV (formerly Corgentech...
BioCentury | Dec 4, 2006
Finance

Ebb & Flow

...for Zingo (3268) to treat pain associated with venous access procedures in children. ANSV (formerly Corgentech...
BioCentury | Nov 28, 2006
Company News

Anesiva submits Zingo NDA

...3268) to treat pain associated with venous access procedures in children. ANSV (formerly known as Corgentech...
BioCentury | Nov 22, 2006
Financial News

Anesiva raises $45 million

...The shares were sold from an existing shelf registration. ANSV, which was formerly known as Corgentech...
Items per page:
1 - 10 of 167